Latest Breaking News On - Suvretta capital - Page 1 : comparemela.com

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesExchange commissionCompany biologics license applicationSecurities exchangeNicolaus company incorporatedCorporate communicationsProspectus departmentAbeona therapeutics incTherapeutics announces pricingUnderwritten offeringCommon stockAdage capital partnersJanus henderson investorsNantahala capitalSuvretta capital

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40 0 Million

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40 0 Million
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United statesIrina kofflerKishen mehtaLifesci advisorsSuvretta capital managementDrug administrationBenitec biopharma incExchange commissionSecurities exchangeNantahala capitalSuvretta capitalSecurities actOculopharyngeal muscular dystrophySecurities exchange actInvestor relations contactSci advisors

Benitec Biopharma (BNTC) Announces $40M Placement at $4 80/sh

Benitec Biopharma (BNTC) Announces $40M Placement at $4 80/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kishen mehtaBenitec biopharma incSuvretta capital managementExchange commissionBenitec biopharmaNantahala capitalSuvretta capitalSecurities act

Zura Bio Announces Oversubscribed $112 5 Million Private Placement

- Financing includes new and existing leading life sciences institutional investors - Strengthened balance sheet expected to fund operations through 2027 .

United statesZura bioPiper sandlerZura bio limited nasdaqExchange commissionGreat point partnersZura bio limitedPrivate placementAccess biotechnologyDeep track capitalSuvretta capitalAllostery investmentsArmistice capitalGuggenheim securitiesSecurities actPrivate securities litigation reform act

Two Rare Disease Drug Developers Raise Combined $152 5 Million in PIPE Offerings

Two Rare Disease Drug Developers Raise Combined $152 5 Million in PIPE Offerings
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Benitec biopharmaZura bioRare dailyDeep track capitalGreat point partnersSuvretta capitalAllostery investmentsArmistice capitalSuvretta capital managementAdage capital partnersNantahala capital